SHARPS TECHNOLOGY INC. - COMMON STOCK

Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems

07 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia

21 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

16 Feb 2024 14:42:54 By Nasdaq GlobeNewswire

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems

18 Jan 2024 09:00:47 By Nasdaq GlobeNewswire

Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement

29 Sep 2023 09:54:45 By Nasdaq GlobeNewswire

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

28 Sep 2023 10:52:52 By Nasdaq GlobeNewswire

UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules

27 Sep 2023 12:03:45 By Nasdaq GlobeNewswire

Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules

27 Sep 2023 09:14:00 By Nasdaq GlobeNewswire

Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals

26 Sep 2023 08:30:00 By Nasdaq GlobeNewswire

Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

12 Jul 2023 08:33:00 By Nasdaq GlobeNewswire

Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article

06 Jul 2023 07:50:00 By Nasdaq GlobeNewswire

Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes

04 Apr 2023 08:00:01 By Nasdaq GlobeNewswire

Sharps Technology Appoints Justin Page as Vice President of Technical Operations

09 Feb 2023 09:21:23 By Nasdaq GlobeNewswire

Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market

06 Feb 2023 09:02:30 By Nasdaq GlobeNewswire

Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market

01 Feb 2023 09:20:00 By Nasdaq GlobeNewswire

Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization

31 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023

10 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products

20 Dec 2022 08:00:00 By Nasdaq GlobeNewswire

Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products

13 Dec 2022 08:00:01 By Nasdaq GlobeNewswire

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership

10 Nov 2022 16:05:03 By Nasdaq GlobeNewswire